Cigna’s stock sinks after double…

Shares of Cigna Corp. CI, -2.61% sank 3.9% in midday trading Friday, after BofA Securities analyst Kevin Fischbeck reversed his stance on the health services company to bearish from bullish, citing the lack of clarity on the trajectory of earnings over the next couple of years. Fischbeck double downgraded Cigna to underperform from buy, and cut his stock price target to $225 from $240. He said that although Cigna has now integrated Express Scripts successfully (the acquisition closed in December 2018), reduced debt and sold off underperforming units, the growth outlook from here is less clear. “[Cigna’s] business mix has the slowest end-market growth of any MCO [managed-care organization] we cover, dominated by commercial and PBM [pharmacy benefit manager] services and therefore requires consistent share gains to match peer growth,” Fischbeck wrote in a note to clients. He also said that Cigna’s third-quarter guidance appears “especially at risk” given concerns over MCO medical loss ratios. Cigna’s stock has lost 1.2% year to date, while the SPDR Health Care Select Sector ETF XLV, -0.02% has climbed 18.4% and the S&P 500 SPX, -0.57% has advanced 19.7%.


Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.